Abstract
Objectives The absence of high-level evidence about treatment approaches in tinnitus has eluded the clinical community from arriving at the consensus to date. This could be partially attributable to a limited number of trials. The objective of the present scoping review was to check updates in existing knowledge about tinnitus management and provide recommendations for further research and practice.
Design Scoping review with Population, Concept, and Context (PCC) framework. Review question(s) for our study were:
Is there any knowledge update from the published evidence on the treatment of tinnitus after the scoping review on tinnitus by Makar S et al. 2017?
Are there any therapies existing that do not focus on habituation but target the root cause of tinnitus?
Which pharmacological interventions are used in the treatment of tinnitus?
Methods The database of our literature search included PubMed, Joanna Briggs Evidence synthesis, Cochrane Library, Scopus, and Google Scholar. We included full-text original articles (randomized controlled trials (RCTs), systematic reviews (SLRs), or meta-analyses) published in the English language between 2010-2021. We included only studies that included interventions to treat patients without any focus on the patient’s habituation or natural adaptation. We excluded reviews, case studies, observational studies, and anecdotal evidence.
Patient and Public Involvement Being a secondary data-based analysis, our study did not directly involve any patient.
Results Of 20 included records, 11 SLRs and nine RCTs were found. Non-pharmacological interventions included transcranial magnetic-(TMS) (four studies) and direct current stimulation (tDCS) (three studies), vagus nerve stimulation (VNS) (one study), and hearing aid or combined amplification and sound generator (two studies); however, despite causing moderate improvement in tinnitus severity, neither of these interventions reached statistical significance. Pharmacological interventions included AM-101(two studies), anticonvulsants (one study), and antidepressants (one study) with insufficient strength to establish the efficacy of either. Also, a specific extract of the Ginkgo Biloba (EGb 761®) plant demonstrated a reduction in tinnitus severity (1 study). No studies included actionable insights on the quality of life (QoL) outcomes.
Conclusions Despite the lack of actionable evidence for tDCS and rTMS like therapies, their curative potential cannot be overlooked. Hence, it is recommended to conduct large-scale trials on similar interventions. Also, aspects like patient-reported outcomes (PROs) in tinnitus.
Protocol registration The protocol was registered in the open science framework registry (OSF) (registration DOI:10.17605/OSF.IO/R8D39)
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study received no funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Being a scoping review, it does not require ethics committee approval.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos